The Structural Genomics Consortium (SGC) is a public-private partnership to promote the development of new medicines by carrying out basic science of relevance to drug discovery. The core mandate of the SGC is to determine 3D structures of proteins of biomedical importance and proteins that represent potential drug targets, and place them in the public domain without restriction.